001     303034
005     20250723114147.0
024 7 _ |a 10.1182/bloodadvances.2024014570
|2 doi
024 7 _ |a pmid:39993233
|2 pmid
024 7 _ |a pmc:PMC12268538
|2 pmc
024 7 _ |a 2473-9529
|2 ISSN
024 7 _ |a 2473-9537
|2 ISSN
037 _ _ |a DKFZ-2025-01481
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Knabe, Ricarda
|b 0
245 _ _ |a Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups.
260 _ _ |a Washington, DC
|c 2025
|b American Society of Hematology
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1753189393_32229
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Muller, Philippe
|0 0009-0000-0985-7666
|b 1
700 1 _ |a Schliemann, Christoph
|0 0000-0003-1755-9583
|b 2
700 1 _ |a Hanoun, Maher
|0 0000-0002-1754-8940
|b 3
700 1 _ |a Unglaub, Julia Marie
|0 0000-0002-3577-5493
|b 4
700 1 _ |a Weinbergerová, Barbora
|0 0000-0001-6460-2471
|b 5
700 1 _ |a Mayer, Jiří
|b 6
700 1 _ |a Krekeler, Carolin
|0 0009-0000-1808-5928
|b 7
700 1 _ |a Krause, Stefan W
|0 0000-0002-5259-4651
|b 8
700 1 _ |a Kaufmann, Martin
|b 9
700 1 _ |a Kraus, Sabrina
|0 0000-0001-8954-4220
|b 10
700 1 _ |a Steffen, Björn
|b 11
700 1 _ |a Modemann, Franziska
|0 0000-0002-5897-3310
|b 12
700 1 _ |a Subklewe, Marion
|0 0000-0001-9154-9469
|b 13
700 1 _ |a Bücklein, Veit
|0 0000-0001-7391-7280
|b 14
700 1 _ |a Kunz, Wolfgang G
|0 0000-0002-5021-1952
|b 15
700 1 _ |a Rudelius, Martina
|0 0000-0001-6928-9955
|b 16
700 1 _ |a von Bergwelt-Baildon, Michael
|0 0000-0002-1952-052X
|b 17
700 1 _ |a Gutmair, Katja
|0 0009-0002-3948-6186
|b 18
700 1 _ |a Hoster, Eva
|0 0000-0002-0749-1389
|b 19
700 1 _ |a Herold, Tobias
|0 0000-0002-9615-9432
|b 20
700 1 _ |a Röllig, Christoph
|0 0000-0002-3791-0548
|b 21
700 1 _ |a Spiekermann, Karsten
|0 P:(DE-He78)b644c56548aced1dd9cf0e858ff30f85
|b 22
773 _ _ |a 10.1182/bloodadvances.2024014570
|g Vol. 9, no. 13, p. 3336 - 3339
|0 PERI:(DE-600)2876449-3
|n 13
|p 3336 - 3339
|t Blood advances
|v 9
|y 2025
|x 2473-9529
909 C O |o oai:inrepo02.dkfz.de:303034
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 0000-0001-9154-9469
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 0000-0002-1952-052X
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 22
|6 P:(DE-He78)b644c56548aced1dd9cf0e858ff30f85
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
914 1 _ |y 2025
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BLOOD ADV : 2022
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-07-05T12:07:28Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-07-05T12:07:28Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2024-07-05T12:07:28Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-16
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-16
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b BLOOD ADV : 2022
|d 2024-12-16
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-16
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-16
920 1 _ |0 I:(DE-He78)MU01-20160331
|k MU01
|l DKTK Koordinierungsstelle München
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)MU01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21